Ligand profile
ZINC9532170
Virtual-screening candidate from ZINC.
Bound to: KP13_02514 — 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC9532170- UniProt (similar protein)
Q2SWT6- Tanimoto
- 0.744
- Target protein
- KP13_02514
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 68.5
- −1 ≤ LogP ≤ 5 1.37
- MW ≤ 500 Da 240.3
- LogP ≤ 5 1.37
- H-bond donors ≤ 5 1
- H-bond acceptors ≤ 10 6
- Rotatable bonds ≤ 10 3
- TPSA ≤ 140 Ų 68.5
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
Cn1ncc2c(NCc3ccncc3)ncnc21Cn1ncc2c(NCc3ccncc3)ncnc21
InChI=1S/C12H12N6/c1-18-12-10(7-17-18)11(15-8-16-12)14-6-9-2-4-13-5-3-9/h2-5,7-8H,6H2,1H3,(H,14,15,16)InChI=1S/C12H12N6/c1-18-12-10(7-17-18)11(15-8-16-12)14-6-9-2-4-13-5-3-9/h2-5,7-8H,6H2,1H3,(H,14,15,16)
HPNLQHRDESJQJD-UHFFFAOYSA-NHPNLQHRDESJQJD-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- CHEMBL1592555
- Homolog
- Q2SWT6
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC9532170 →
- ZINC ZINC20 ZINC9532170 →
- UniProt UniProt Q2SWT6 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC9532170”) →
Other ligands for this protein
Quick navigation to other ligands bound to KP13_02514.
PDB 7
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 6
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).